{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:55:59Z","timestamp":1775044559883,"version":"3.50.1"},"reference-count":58,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/17474086.2026.2634277","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:36:13Z","timestamp":1771324573000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The emerging role of complement inhibitory approaches in the treatment of acute sickle cell disease complications"],"prefix":"10.1080","volume":"19","author":[{"given":"Haley","family":"Cowan","sequence":"first","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronak","family":"Dave","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]},{"name":"Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshaya","family":"Arjunan","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]},{"name":"Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Maarouf","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]},{"name":"Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Dean","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Graciaa","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Schoettler","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]},{"name":"Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-0800","authenticated-orcid":false,"given":"Satheesh","family":"Chonat","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta","place":["Atlanta, USA"]},{"name":"Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06794.x"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80074-7"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7299-9_3"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21699"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1645"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903212"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715971"},{"key":"e_1_3_5_12_1","unstructured":"Novartis. European commission (EC) adopts decision endorsing CHMP recommendation to revoke the conditional marketing authorization for adakveo (crizanlizumab). Novartis; 2023. Available from: https:\/\/www.novartis.com\/news\/european-commission-ec-adopts-decision-endorsing-chmp-recommendation-revoke-conditional-marketing-authorization-adakveo-crizanlizumab"},{"key":"e_1_3_5_13_1","unstructured":"FDA. FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns. 2024."},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000821"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-715870"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30283-0"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2025.08.018"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224709"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.262006"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000610"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96910"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25742"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019282"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl4922"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31061"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127176"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1344"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(96)00078-8"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13108-2"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195909"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1923366"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2022.2073215"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876136"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029073"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00315-0"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27413"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1297352"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2022.06.018"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308695"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147854"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179858"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1857723"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01524-6"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2019.02.002"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24460"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194670"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-669770"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001143"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008058"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104205"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901876"},{"key":"e_1_3_5_52_1","first-page":"1","article-title":"Critical role of C5a in sickle cell disease","volume":"19","author":"Vercellotti GM","year":"2018","unstructured":"Vercellotti GM, Dalmasso AP, Schaid TR Jr, et al. Critical role of C5a in sickle cell disease. Am J Hematol. 2018;19:1\u201341.","journal-title":"Am J Hematol"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198622"},{"key":"e_1_3_5_54_1","unstructured":"NHS England. Rituximab and eculizumab for the prevention and management of delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies. NHS England; 2020. Available from: https:\/\/www.england.nhs.uk\/publication\/rituximab-and-eculizumab-for-the-prevention-and-management-of-delayed-haemolytic-transfusion-reactions-and-hyperhaemolysis-in-patients-with-haemoglobinopathies\/"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.068965"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2373"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002095"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-278747"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009643"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025176"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2634277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:39:19Z","timestamp":1775039959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2634277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/17474086.2026.2634277"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2634277","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}